Loading…
Welcome to the GICancer Masterclass workshop registration.


Simple
Expanded
Grid
By Venue
Friday, April 26
 

10:30 WEST

Molecular profiling: Current landscape and future development Casablance, Level G1Stephan Singer • Eric Van Cutsem Patient pathway in CCA Berlin B, Level G1Pascal Hammel • Thomas Gruenberger Current treatment landscape & guidelines in mCRC Los Angeles, Level G1Julien Taieb • Chiara Cremolini Patient cases in mCRC Munich, Level G1Jenny Seligmann • Borislav Belev Long term survivals: Clinical experiences Berlin A, Level G1Teresa Macarulla • Angela Lamarca Patient cases in mPAC Geneva, Level G1Gerald Prager • Davide Melisi

11:20 WEST

Molecular profiling: Current landscape and future development Casablance, Level G1Stephan Singer • Eric Van Cutsem Patient pathway in CCA Berlin B, Level G1Pascal Hammel • Thomas Gruenberger Current treatment landscape & guidelines in mCRC Los Angeles, Level G1Julien Taieb • Chiara Cremolini Patient cases in mCRC Munich, Level G1Jenny Seligmann • Borislav Belev Long term survivals: Clinical experiences Berlin A, Level G1Teresa Macarulla • Angela Lamarca Patient cases in mPAC Geneva, Level G1Gerald Prager • Davide Melisi

14:30 WEST

Evolving therapeutic landscape in 1st & 2nd line metastatic CCA Los Angeles, Level G1Teresa Macarulla • Davide Melisi Optimizing MDT in CCA pathway Munich, Level G1Thomas Gruenberger • Stephan Singer Impact of later lines therapies on QoL and ECOG/PS Geneva, Level G1Gerald Prager • Borislav Belev New treatment strategies in the mCRC continuum of care Casablance, Level G1Eric Van Cutsem • Lukas Weiss Continuum of care and role of precision medicine in mPAC Berlin A, Level G1Angela Lamarca Patient management during mPAC treatment Berlin B, Level G1Pascal Hammel • Anabela Barros

15:45 WEST

Evolving therapeutic landscape in 1st & 2nd line metastatic CCA Los Angeles, Level G1Teresa Macarulla • Davide Melisi Optimizing MDT in CCA pathway Munich, Level G1Thomas Gruenberger • Stephan Singer Impact of later lines therapies on QoL and ECOG/PS Geneva, Level G1Gerald Prager • Borislav Belev New treatment strategies in the mCRC continuum of care Casablance, Level G1Eric Van Cutsem • Lukas Weiss Continuum of care and role of precision medicine in mPAC Berlin A, Level G1Angela Lamarca Patient management during mPAC treatment Berlin B, Level G1Pascal Hammel • Anabela Barros
 
Saturday, April 27
 

10:45 WEST

Molecular profiling: Current landscape and future development Casablance, Level G1Stephan Singer • Eric Van Cutsem Patient pathway in CCA Berlin B, Level G1Pascal Hammel • Thomas Gruenberger Current treatment landscape & guidelines in mCRC Los Angeles, Level G1Julien Taieb • Chiara Cremolini Patient cases in mCRC Munich, Level G1Jenny Seligmann • Borislav Belev Long term survivals: Clinical experiences Berlin A, Level G1Teresa Macarulla • Angela Lamarca Patient cases in mPAC Geneva, Level G1Gerald Prager • Davide Melisi

11:35 WEST

Evolving therapeutic landscape in 1st & 2nd line metastatic CCA Los Angeles, Level G1Teresa Macarulla • Davide Melisi Optimizing MDT in CCA pathway Munich, Level G1Thomas Gruenberger • Stephan Singer Impact of later lines therapies on QoL and ECOG/PS Geneva, Level G1Gerald Prager • Borislav Belev New treatment strategies in the mCRC continuum of care Casablance, Level G1Eric Van Cutsem • Lukas Weiss Continuum of care and role of precision medicine in mPAC Berlin A, Level G1Angela Lamarca Patient management during mPAC treatment Berlin B, Level G1Pascal Hammel • Anabela Barros
 
Filter sessions
Apply filters to sessions.
Friday, April 26
Saturday, April 27
Berlin A, Level G1
Berlin B, Level G1
Casablance, Level G1
Geneva, Level G1
Los Angeles, Level G1
Munich, Level G1
  • CCA
  • mCRC
  • mPAC